NIM
ORIC icon

NEOS Investment Management’s Oric Pharmaceuticals ORIC Stock Holding History

NEOS Investment Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,269
Closed -$231K – 636
2025
Q4 		$231K Buy
+28,269
New +$325K ﹤0.01% 648
2025
Q2 		– Sell
-40,934
Closed -$228K – 623
2025
Q1 		$228K Sell
40,934
-4,542
-10% -$39.7K ﹤0.01% 578
2024
Q4 		$367K Buy
+45,476
New +$417K 0.01% 542

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

NEOS Investment Management's ORIC Position: Q1 2026 in Review

NEOS Investment Management sold out of Oric Pharmaceuticals (ORIC) in Q1 2026, closing a stake of 28,269 shares — an estimated $231K sold.

NEOS Investment Management first reported a position in ORIC in Q4 2024 and held it in 3 quarters. The position peaked at $367K in Q4 2024. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • NEOS Investment Management reported no remaining Oric Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • NEOS Investment Management sold 28,269 Oric Pharmaceuticals shares in Q1 2026, an estimated $231K.
  • NEOS Investment Management first reported a position in Oric Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • NEOS Investment Management's Oric Pharmaceuticals position peaked at $367K in Q4 2024.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.